Michael R. Horsman

The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations

Martin O. Leach, Kevin M. Brindle, Jeff Evelhoch et al. · British Journal of Cancer · 2005 · 514 citations · Full text

Medicine, Oncology, Radiology +17

Modification of hypoxia-induced radioresistance in tumors by the use of oxygen and sensitizers

Jens Overgaard, Michael R. Horsman · Seminars in Radiation Oncology · 1996 · 419 citations

Medicine, Cancer Biology, Oncology +12

Comparisons among Pimonidazole Binding, Oxygen Electrode Measurements, and Radiation Response in C3H Mouse Tumors

J A Raleigh, S-C. Chou, Gavin E. Arteel et al. · Radiation Research · 1999 · 304 citations

Medicine, Oncology, Pharmacology +17

Plasma osteopontin, hypoxia, and response to the hypoxia sensitiser nimorazole in radiotherapy of head and neck cancer: results from the DAHANCA 5 randomised double-blind placebo-controlled trial

Jens Overgaard, Jesper Grau Eriksen, Marianne Nordsmark et al. · The Lancet Oncology · 2005 · 274 citations

Medicine, Oncology, Radiation Oncology +14

Differentiation and Definition of Vascular-Targeted Therapies

Dietmar W. Siemann, Michael C. Bibby, G. Dark et al. · Clinical Cancer Research · 2005 · 269 citations · Full text

Medicine, Oncology, Pharmacology +16